Plus   Neg

Stock Alert: Kornit Digital Trading Higher As Co. Is On Recovery Path

Shares of Kornit Digital Ltd. (KRNT), a leading provider of digital printing solutions for the global textile industry, are surging more than 24% Wednesday morning to hit a new high of $46.20. The stock is currently trading lower at $44.54.

Tuesday while talking to analysts during the first-quarter earnings call, Ronen Samuel, Chief Executive Officer of the company said that Kornit Digital is back to strong recovery after hit badly by coronavirus pandemic. The company has reopened all its manufacturing and R&D sites.

"Some major orders we expected in Q1 have already been received in Q2 with partial implementation in Q2 and the remainder in the second half of the year," Samuel added.

During the first quarter, revenue for the quarter decreased to $26.2 million from $38.5 million.

Adjusted net loss for the first quarter was $8.9 million, or $0.22 per share, compared with net income of $1.6 million, or $0.04 per share a year ago.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hyundai Motor has launched a new IONIQ brand dedicated to battery electric vehicles, as the automaker is accelerating its efforts to gain a share in the fast-growing global EV market. Under the IONIQ brand, Hyundai plans to introduce three new dedicated electric vehicle models over the next four years. Hyundai is South Korea's largest automaker. Amazon.com, Inc. is in talks with mall operator Simon Property Group, Inc. to use the abandoned anchor departmental stores of JC Penny and Sears at their malls as fulfillment centers, reports said. This is expected to help the e-commerce giant in boosting their last mile delivery, which is the last leg of the delivery process. The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Follow RTT